Calamos Wealth Management LLC Astrazeneca PLC Transaction History

Calamos Wealth Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	SELL	$61.89 - $69.28 $362,118 - $405,357	-5,851 Reduced 24.25%	18,273 $1.23 Million
Q3 2023 Oct 25, 2023	BUY	$64.85 - $71.7 $539,098 - $596,042	8,313 Added 52.58%	24,124 $1.63 Million
Q2 2023 Jul 28, 2023	SELL	$69.91 - $75.81 $17,687 - $19,179	-253 Reduced 1.57%	15,811 $1.13 Million
Q1 2023 May 03, 2023	BUY	$63.15 - $71.6 $84,305 - $95,585	1,335 Added 9.06%	16,064 $1.12 Million
Q4 2022 Jan 25, 2023	SELL	$54.21 - $70.44 $844,591 - $1.1 Million	-15,580 Reduced 51.4%	14,729 $0
Q3 2022 Oct 24, 2022	SELL	$53.02 - $135.75 $143,843 - $368,289	-2,713 Reduced 8.22%	30,309 $1.66 Million
Q2 2022 Aug 01, 2022	BUY	$59.26 - $71.14 $1.96 Million - $2.35 Million	33,022 New	33,022 $2.18 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Calamos Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Calamos Wealth Management LLC with notifications on news.